My research centers on the use of light and lasers for diagnostics and therapetics. There are two programs ongoing in my lab. One aims to use light-based measurements to identify women with elevated Breast Cancer risk, enabling women to consider risk reduction intervention early in life to prevent the disease. The second program aims to develop Photodynamic therapy or the use of light-activated drugs into personalized therapy. Photodynamic Therapy is largely independent of a cancer's genetic expression, can be delivered in 1-2 days and prevents systemic exposure to toxic substances.
Lothar Lilge, PhD
Senior Scientist, Princess Margaret Cancer Centre